期刊文献+

HPLC-荧光法测定肾移植患者血浆中霉酚酸的浓度 被引量:3

Determination of Plasma Concentration of Mycophenolic Acid in Renal Transplantation Patients by HPLC-Fluoremetry
原文传递
导出
摘要 目的:建立以高效液相色谱-荧光法测定肾移植患者血浆中霉酚酸浓度的方法。方法:样品用5%硫酸锌的甲醇饱和溶液沉淀蛋白后,取上清液进样20μL进行测定,色谱柱为Zorbax Eclipse XDBC18,流动相为乙腈-甲醇-0.2mol·L-1甘氨酸缓冲液(pH9.0)=18∶2∶80,柱温为25℃,流速为1.0mL·min-1,激发波长(EX)为342nm,发射波长(EM)为425nm。结果:霉酚酸血药浓度在0.5~40mg·L-1范围内线性关系良好,最低定量限为0.5mg·L-1;方法回收率为98.23%~101.00%,萃取回收率为91.56%~94.46%,日内、日间RSD分别为0.64%~3.22%和5.12%~6.10%。结论:本方法灵敏、快速、准确、方便,可用于霉酚酸的血药浓度测定。 OBJECTIVE: To determine the plasma concentration of mycophenolic acid (MPA) in renal transplantation patients by HPLC- Fluoremetry. METHODS: The sample was subjected to precipitation of proteins using 5% Zinc Sulfate methanol saturated solution, and the supernatant (20μL) was taken for sample injection and determination on Zorbax Eclipse XDB C18 with mobile phase consisted of acetonitrile - methanol - 0.2 mol·L^-1glycine buffer(18 : 2 : 80, pH = 9.0) at a flow rate of 1.0 mL·min^-1. The column temperature was of 25℃ ; the excitation wavelength(Ex) was 342 nm and the emission wavelength(EM) was 425 nm. RESULTS: The linear range of MPA was 0.5-40 mg·L^-1, with its lowest limit of quantita- tion at 0.5 mg·L^-1. The methodology recovery was 98.23% --101.00% ; the extraction recovery of MPA was 91.56%- 94.46%; the intraday RSD was 0.64%- 3.22% and the inter- day RSD was 5.12%--6.10%. CONCLUSION: The method is sensitive, rapid, accurate, convenient, and applicable for the quantitative determination of plasma concentration of MPA in renal transplantation patients.
出处 《中国药房》 CAS CSCD 北大核心 2009年第17期1318-1319,共2页 China Pharmacy
关键词 霉酚酸 肾移植 高效液相色谱-荧光法 血药浓度 Mycophenolic acid Renal transplantation HPLC-Fluoremetry Plasma concentration
  • 相关文献

参考文献3

  • 1周佩军,徐达,王祥慧,余自成,赵菊平.肾移植受者霉酚酸治疗药物监测[J].上海交通大学学报(医学版),2006,26(6):680-684. 被引量:11
  • 2Yu ZC, Zhou PJ, Xu D.et al. Investigation on pharmacokinetics of myeophenolic acid in Chinese adult renal transplant patients[J]. British Journal of Clinical Pharmacology, 2006,10(11) : 1 365.
  • 3Nobuyuki S, Takayuki S. Clinical pharmacokinetics of mycophenolate mofetil in japanese renal transplant recipients: a retrospective cohort study in a single center [J ]. Biol Pharm Bull, 2006,29(10) : 2 099.

二级参考文献14

  • 1Allson AC,Eugui EM.Immunosuppressive and other effects of mycophenolic acid and an ester prodrug,mycophenolate mofetil[J].Immunol Rev,1993,136:5-28.
  • 2Sievers TM,Rossi SJ,Ghobrial RM,et al.Mycophenolate mofetil[J].Pharmacotherapy,1997,17(6):1178-1197.
  • 3The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.A blinded,randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation[J].Transplantation,1996,61(7):1029-1037.
  • 4Cattaneo D,Gaspari F,Ferrari S,et al.Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients[J].Clin Transplant,2001,15(6):402-409.
  • 5Atcheson BA,Taylor PJ,Mudge DW,et al.Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant[J].Br J Clin Pharmacol,2005,59(3):271-280.
  • 6Shaw LM,Korecka M,Aradhye S,et al.Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable[J].J Clin Pharmacol,2000,40(6):624-633.
  • 7Bullingham RE,Nicholls A,Hale M.Pharmacokinetics of mycophenolate mofetil (RS61443):a short review[J].Transplant Proc,1996,28(2):925-929.
  • 8Bland JM,Altman DG.Statistical methods for assessing agreement between two methods of clinical measurement[J].Lancet,1986,1(8476):307-310.
  • 9Touw DJ,Neef C,Thomson AH,et al.Cost-Effectiveness of Therapeutic Drug Monitoring Committee of the International Association for Therapeutic Drug Monitoring and Clinical Toxicology.Cost-effectiveness of therapeutic drug monitoring:a systematic review[J].Ther Drug Monit,2005,27(1):10-17.
  • 10Yamani MH,Starling RC,Goormastic M,et al.The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection[J].Transplantation,2000,69(11):2326-2330.

共引文献10

同被引文献19

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部